Edition:
United Kingdom

Xenon Pharmaceuticals Inc (XENE.OQ)

XENE.OQ on NASDAQ Stock Exchange Global Market

10.48USD
12 Oct 2018
Change (% chg)

$0.31 (+3.05%)
Prev Close
$10.17
Open
$10.33
Day's High
$10.63
Day's Low
$10.33
Volume
47,270
Avg. Vol
38,744
52-wk High
$15.90
52-wk Low
$2.15

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.454
Mar '18 0.00 -0.268
FY 2017 Dec '17 0.02 -0.448
Sep '17 0.26 -0.430
Jun '17 0.01 -0.410
Mar '17 0.02 -0.419
FY 2016 Dec '16 0.38 -0.335
Sep '16 0.41 -0.505
Jun '16 0.41 -0.418
Mar '16 0.60 -0.227
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 2 6.25 12.50 0.00 --
Year Ending Dec-18 3 4.17 12.50 0.00 3.00
Year Ending Dec-19 3 3.33 10.00 0.00 3.00
Earnings (per share)
Quarter Ending Dec-18 2 -0.17 0.15 -0.48 --
Year Ending Dec-18 3 -1.33 -0.96 -1.59 -1.53
Year Ending Dec-19 3 -1.73 -1.52 -1.91 -1.57
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.91 32.75
P/E High - Last 5 Yrs. 21.51 301.66 45.42
P/E Low - Last 5 Yrs. 21.51 92.42 24.25
Beta -- 0.93 0.89
Price to Sales (TTM) 65.85 115.65 5.74
Price to Book (MRQ) 1.07 15.58 5.00
Price to Tangible Book (MRQ) 1.07 14.67 6.57
Price to Cash Flow (TTM) -- 73.07 23.28
% Owned Institutions 63.38 14.71 2.26

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.51
Dividend Yield - 5 Year Avg -- 0.25 1.52
Dividend 5 Year Growth Rate -- 1.73 5.24
Payout Ratio(TTM) -- 16.54 43.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -96.37 413.24 8.00
Sales (TTM) vs TTM 1 Yr. Ago -90.39 79.21 5.62
Sales - 5 Yr. Growth Rate -23.58 32.28 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 1.79 27.96 20.60
EPS (TTM) vs TTM 1 Yr. Ago -40.79 -- --
EPS - 5 Yr. Growth Rate -- 40.04 10.66
Capital Spending - 5 Yr. Growth Rate -0.77 40.58 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 13.95 5.19 3.03
LT Debt to Equity (MRQ) 0.00 35.49 12.55
Total Debt to Equity (MRQ) 0.00 37.32 16.89
Interest Coverage (TTM) -9.68 -102.94 32.71

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.99 54.34
Gross Margin - 5 Yr. Avg. -- 50.37 52.13
EBITD Margin (TTM) -3,415.37 -- --
EBITD - 5 Yr. Avg -14.16 -605.43 10.68
Operating Margin (TTM) -3,496.71 -764.71 4.33
Operating Margin - 5 Yr. Avg. -18.89 -626.59 6.11
Pre-Tax Margin (TTM) -3,489.63 -738.48 5.20
Pre-Tax Margin - 5 Yr. Avg. -20.59 -632.35 6.52
Net Profit Margin (TTM) -3,489.63 -739.84 1.49
Net Profit Margin - 5 Yr. Avg. -20.59 -635.37 2.79
Effective Tax Rate (TTM) -- 23.37 23.12
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) 9,318 23,344,613 859,711,668
Net Income/Employee (TTM) -325,170 3,159,253 101,129,378
Receivable Turnover (TTM) 1.92 20.76 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.01 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.07 -0.24 11.13
Return on Assets - 5 Yr. Avg. -- 3.46 12.40
Return on Investment (TTM) -55.45 1.70 14.60
Return on Investment - 5 Yr. Avg. -- 2.51 16.13
Return on Equity (TTM) -55.50 3.17 16.33
Return on Equity - 5 Yr. Avg. -- 3.37 17.39
  1 Year 3 Year 5 Year
Sales % -88.43 -59.61 -23.58
EPS (TTM) % -34.58 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Xenon Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 33.62%
# of Holders: 46
Total Shares Held: 8,407,270
3 Mo. Net Change: -856,205
# New Positions: 4
# Closed Positions: 2
# Increased Positions: 4
# Reduced Positions: 5
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.